SCYNEXIS Secures $62,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cf661df5-cd69-42ec-b6e3-a61a96e9599b - Date
5/2/2014 - Company Name
SCYNEXIS - Mailing Address
3501 C Tricenter Boulevard Durham, NC 27713 USA - Company Description
SCYNEXIS, Inc. (NASDAQ: SCYX) is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas. - Website
http://www.scynexis.com - Transaction Type
IPO - Transaction Amount
$62,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
